Iron Triangle Partners LP Acadia Pharmaceuticals Inc Transaction History
Iron Triangle Partners LP
- $708 Million
- Q3 2024
A detailed history of Iron Triangle Partners LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Iron Triangle Partners LP holds 750,000 shares of ACAD stock, worth $12.7 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
750,000Holding current value
$12.7 Million% of portfolio
1.63%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
279Shares Held
156MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$727 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$235 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$232 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$204 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$101 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.74B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...